CREBBP and lung adenocarcinoma: Moreover, lung adenocarcinomas patients with very weak or negative CBP and hTERT expression have nearly 100% survival rate of 8 years after diagnosis, but the survival rate for the patients with both high CBP and hTERT expression was lowered to 50% 5 years after diagnosis (Fig. 5D), suggesting the important role of CBP expression and its association with hTERT in predicting the prognosis of patients with lung adenocarcinomas.